Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes
Open accessThe DOI matches its Crossref record; 15 of the 16 references it cites were found in a registry or an index; 12 of the 23 sources its claims cite were checked for support.
Abstract
OBJECTIVE: Use of Carpenter-Coustan compared with National Diabetes Data Group criteria increases the number of women diagnosed with gestational diabetes mellitus (GDM) by 30-50%, but whether treatment of this milder GDM reduces adverse outcomes is unknown. We explored the effects of the diagnostic criteria used on the benefits of GDM treatment. METHODS: This was a secondary analysis of a randomized trial for treatment of mild GDM diagnosed using Carpenter-Coustan criteria. We evaluated the effect of treatment within two mutually exclusive diagnostic groups: 1) women who met the stricter National Diabetes Data Group as well as Carpenter-Coustan criteria (National Diabetes Data Group), and 2) those diagnosed by Carpenter-Coustan but not meeting National Diabetes Data Group criteria (Carpenter-Coustan only). Maternal outcomes examined were pregnancy-induced hypertension, shoulder dystocia, maternal weight gain, and cesarean delivery. Neonatal outcomes were large for gestational age, macrosomia (greater than 4,000 g), fat mass, small for gestational age, and a composite outcome of perinatal death, birth injury, hypoglycemia, hyperbilirubinemia, and hyperinsulinemia. Analysis of variance or the Breslow-Day test, as appropriate, was used to test for the interaction between diagnostic criteria and GDM treatment on the outcomes of interest. RESULTS: Of 958 patients, 560 (58.5%) met National Diabetes Data Group criteria and 398 (41.5%) met Carpenter-Coustan only. Compared with untreated women, the direction of treatment effect did not differ by diagnostic criteria used and was consistent with the original trial. The P value for interaction between diagnostic criteria and treatment status was not significant for any outcome. CONCLUSION: The overall beneficial treatment effect on pregnancy-induced hypertension, shoulder dystocia, cesarean delivery, and macrosomia was seen in patients diagnosed by the higher National Diabetes Data Group and by the lower thresholds of the Carpenter-Coustan criteria.
Overview
CoChat Summary
TL;DR
In a secondary analysis of a randomized trial of mild gestational diabetes treatment, women diagnosed by Carpenter-Coustan criteria alone and those meeting the stricter NDDG criteria both appeared to benefit from treatment. The direction of treatment effect was consistent with the original trial, and no significant interaction between diagnostic criteria and treatment was found for any outcome.
Key findings
- Of 958 women diagnosed with GDM in the primary study, 560 (58.5%) met NDDG criteria and 398 (41.5%) met Carpenter-Coustan criteria only; 931 (97.2%) had outcomes data available.
- The direction of treatment effect did not differ by diagnostic criteria and was consistent with the original trial; the p-value for interaction between diagnostic criteria and treatment status was not significant for any maternal or neonatal outcome.
- With the exception of shoulder dystocia, numbers needed to treat were small (20 or less for the overall group) and similar between NDDG and Carpenter-Coustan criteria.
- The overall beneficial treatment effect on pregnancy-induced hypertension, shoulder dystocia, cesarean delivery, and macrosomia was seen in patients diagnosed by the higher NDDG thresholds and by the lower Carpenter-Coustan thresholds.
Methods
- Secondary analysis of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network randomized clinical trial for treatment of mild GDM; women at 24 weeks 0 days to 30 weeks 6 days with a 1-hour glucose challenge test of 135–200 mg/dL underwent a 3-hour glucose tolerance test, and mild GDM was defined by fasting glucose <95 mg/dL plus at least two glucose values exceeding Carpenter-Coustan thresholds.
- Women were randomized to usual care or treatment including nutritional counseling, diet therapy, and insulin if needed; this analysis compared two mutually exclusive groups: those meeting NDDG criteria and those meeting Carpenter-Coustan criteria only.
- Analysis of variance or the Breslow-Day test for homogeneity was used to test interaction between diagnostic criteria and GDM treatment; number needed to treat was calculated for the overall group, NDDG group, and Carpenter-Coustan group.
Limitations
- The paper states that stratifying the cohort into two diagnostic criteria groups naturally limited power to detect differences between treated and untreated women within each group, and that lack of statistical power cannot be completely ruled out.
- The paper states that no adjustments were made for multiple comparisons.
- Evident from the text: this was a secondary analysis, and outcomes were selected from the primary study for which treatment of mild GDM was beneficial, which may limit inference about outcomes not selected.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 0 Not valid · 5 Not checked · 24 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Although in the original study treatment did not demonstrate a reduction in the incidence of the primary outcome compared to usual care”
§ Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes > Materials and Methods
What the sources say
- Supportedcites [12] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B A multicenter, randomized trial of treatment for mild gestational diabetes The New England journal of medicine 2009 10 1 361 14 1339 48 19797280 PMC2804874 source
The Results (Perinatal and Neonatal Outcomes) report no significant difference in the composite primary outcome between treatment and usual care (32.4% vs. 37.0%; P = 0.14). The Discussion likewise states that treatment did not reduce its frequency. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several prior retrospective studies have demonstrated that women meeting the Carpenter-Coustan criteria for GDM had worse perinatal outcomes (increased odds of operative delivery, shoulder dystocia, LGA, macrosomia, or preeclampsia) compared to women not diagnosed with gestational diabetes.(6-9)”
§ Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes > Introduction
What the sources say
- Partly supportedcites [6] Ricart W Lopez J Mozas J Pericot A Sancho MA Gonzalez N Potential impact of American Diabetes Association (2000) criteria for diagnosis of gestational diabetes mellitus in Spain Diabetologia 2005 6 48 6 1135 41 15889233 sourceExperimental — accuracy not yet measured
The Results report increased odds of LGA newborns and pregnancy-induced hypertension in women with ADA-only GDM compared with negative screenees. They do not show a significant increase in macrosomia or Caesarean section for that group, and the supplied passages do not report shoulder dystocia or a separate pre-eclampsia result. Page numbers are not available in our copy. (LLM, conf=0.86)
- Partly supportedcites [7] Berggren EK Boggess KA Stuebe AM Jonsson Funk M National Diabetes Data Group vs Carpenter-Coustan criteria to diagnose gestational diabetes American journal of obstetrics and gynecology 2011 9 205 3 253 e1 7 22071053 PMC3670957 sourceExperimental — accuracy not yet measured
The Results (page unavailable) report higher risks of cesarean delivery, macrosomia, and preeclampsia among women meeting only Carpenter–Coustan criteria than among women with a negative diagnostic test. The Comment discusses similar findings in prior studies, but describes their shoulder-dystocia comparison against women meeting NDDG criteria, not women without GDM. The passages do not establish the claimed increase in LGA or the full list of outcomes against the stated comparator. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [8] Cheng YW Block-Kurbisch I Caughey AB Carpenter-Coustan criteria compared with the national diabetes data group thresholds for gestational diabetes mellitus Obstetrics and gynecology 2009 8 114 2 Pt 1 326 32 19622994 source
- Not checked — no full text of the sourcecites [9] Chou CY Lin CL Yang CK Yang WC Lee FK Tsai MS Pregnancy outcomes of Taiwanese women with gestational diabetes mellitus: a comparison of Carpenter-Coustan and National Diabetes Data Group criteria Journal of women’s health (2002) 2010 5 19 5 935 9 20370431 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Treatment of mild GDM also reduced maternal gestational weight gain”
§ Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes > Materials and Methods
What the sources say
- Supportedcites [12] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B A multicenter, randomized trial of treatment for mild gestational diabetes The New England journal of medicine 2009 10 1 361 14 1339 48 19797280 PMC2804874 source
The Results, under Maternal Outcomes, state that weight gain from enrollment to delivery was lower in the treatment group than in the control group. This supports the claim, with the measurement period specified as enrollment to delivery. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“neonatal fat mass”
§ Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes > Materials and Methods
What the sources say
- Supportedcites [12] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B A multicenter, randomized trial of treatment for mild gestational diabetes The New England journal of medicine 2009 10 1 361 14 1339 48 19797280 PMC2804874 source
The Results section (Perinatal and Neonatal Outcomes) states that mean neonatal fat mass was significantly reduced in the treatment group compared with the control group. The Abstract Results report 427 g versus 464 g. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“large for gestational age infants”
§ Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes > Materials and Methods
What the sources say
- Supportedcites [12] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B A multicenter, randomized trial of treatment for mild gestational diabetes The New England journal of medicine 2009 10 1 361 14 1339 48 19797280 PMC2804874 source
The Results (Perinatal and Neonatal Outcomes) report that large-for-gestational-age infants were significantly less frequent in the treatment group than in the control group. The Abstract (Results) gives the rates as 7.1% versus 14.5%. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
15 more claims · 2 with their cited sources checked
Create a free account to see all 40 claims and every source verdict.
- Probably not a substantial claim. 10
- It may state two separate claims as one. 11
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 4×
“Several prior retrospective studies have demonstrated that women meeting the CarpenterCoustan criteria for GDM had worse perinatal outcomes (increased odds of operative delivery, shoulder dystocia, large for gestational age, macrosomia, or preeclampsia) compared with women not diagnosed with GDM.6–9 In these studies,…”
MethodInfluentialSelf-citationPractice Bulletin No. 137: Gestational Diabetes Mellitus
(2013) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000433006.09219.f1 · Cited by 581
Alexander, G. R., Kogan, M. D., & Himes, J. H. (1999) · Maternal and Child Health Journal · doi:10.1023/a:1022381506823 · Cited by 250 · cited 1×
“reference population).(13) Trained study personnel collected antepartum, intrapartum, and postdelivery data for enrolled women and their newborns at the time of discharge from the hospital.”
BackgroundInfluence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity.
Magee, M. S., Walden, C. E., Benedetti, T. J., & Knopp, R. H. (1993) · PubMed · Cited by 160
(1998) · PubMed · Cited by 150
The relationship between maternal glycemia and perinatal outcome
Landon, M. B., Mele, L., Spong, C. Y., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318203ebe0 · Cited by 150
Self-citation(2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31829c3e64 · Cited by 124
Ricart, W., López, J., Mozas, J., Pericot, A., Sancho, M. A., González, N., Balsells, M., Luna, R., Cortázar, A., Navarro, P., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1756-9 · Cited by 118 · cited 1×
“In a large prospective cohort in Spain, women with untreated GDM diagnosed by Carpenter-Coustan criteria had increased risks of pregnancy-induced hypertension and LGA neonates compared with glucose-tolerant women.(6) Berggren et al(7) compared outcomes in women with untreated GDM diagnosed by Carpenter-Coustan with th…”
ResultInfluence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity
Magee, M. S. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500050087031 · Cited by 99
Research works printed but not linked: 1
- 2013, Practice Bulletin No. 137. American College of Obstetricians and Gynecologists., Obstet Gynecol, 122, 406
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
Metadata
- Authors
- Harper, L. M., Mele, L., Landon, M. B., Carpenter, M. W., Ramin, S. M., Reddy, U. M., Casey, B., Wapner, R. J., Varner, M. W., Thorp, J. M., Sciscione, A., Catalano, P., Harper, M., Saade, G., Caritis, S. N., Sorokin, Y., Peaceman, A. M., & Tolosa, J. E.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Northwestern University (US)
- ORCID
- Venue
- Obstetrics & Gynecology
- Published
- 2016-05
- Volume
- 127
- Issue
- 5
- Pages
- 893-898
- ISSN
- 0029-7844 (ISSN-L)
- PMC
- PMC4840065
- OpenAlex
- W2341996597
- Cited by
- 56
- References
- 16
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 11 · 2023: 3 · 2022: 2 · 2021: 11 · 2020: 8 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 1
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000439)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079626)
- National Center for Research Resources (C06RR011234, M01RR000080, UL1RR024989, UL1RR025764, M01RR000064, M01RR000034)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U01HD036801, U10HD040544, U10HD034208, U10HD040512, UG1HD034116, UG1HD053097, U10HD027915, U10HD040545, U10HD040560, U10HD027917, U10HD036801, U10HD027860, U10HD021410, U10HD053097, U10HD034116, U10HD040500, U10HD040485, P2CHD050924, U10HD053118, U10HD027869, U10HD034136, UG1HD034208, U24HD036801, UG1HD040500, UG1HD040512, UG1HD027869, UG1HD040544, UG1HD040485, UG1HD027915, UG1HD040560, UG1HD040545)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- gestational diabetes mellitus, Carpenter and Coustan criteria, National Diabetes Data Group criteria, diagnostic criteria, insulin therapy, gestational hypertension, shoulder dystocia, cesarean section, macrosomia, large for gestational age, neonatal outcomes, perinatal outcomes, birth trauma
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Female, Humans, Pregnancy, Prenatal Diagnosis, Sensitivity and Specificity, United States, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes. https://app.cochat.ai/papers/10.1097/aog.0000000000001383
- The paper
- Harper, L. M., Mele, L., Landon, M. B., Carpenter, M. W., Ramin, S. M., Reddy, U. M., Casey, B., Wapner, R. J., Varner, M. W., Thorp, J. M., Sciscione, A., Catalano, P., Harper, M., Saade, G., Caritis, S. N., Sorokin, Y., Peaceman, A. M., & Tolosa, J. E. (2016). Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000001383
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.